These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Penicillamine and other therapeutic methods in the treatment of Wilson's disease]. Czlonkowska A, Czlonkowski A. Neurol Neurochir Pol; 1975; 9(3):401-6. PubMed ID: 1097955 [No Abstract] [Full Text] [Related]
23. Wilson's disease: the role of penicillamine. Carmichael BM. Mil Med; 1969 Oct; 134(11):1336-9. PubMed ID: 4980975 [No Abstract] [Full Text] [Related]
30. [Immunologic studies with the lymphocyte transformation test on the side effects of D-penicillamine therapy in Wilson's disease]. Storch W, Berger H. Z Gesamte Inn Med; 1980 Jul 01; 35(13):567-70. PubMed ID: 7445606 [Abstract] [Full Text] [Related]
31. [Hepatolenticular degeneration, Wilson's disease. A characteristics case with remission under penicillamine therapy]. Hansen J, Andersen OS. Ugeskr Laeger; 1969 Jul 31; 131(31):1306-9. PubMed ID: 5824791 [No Abstract] [Full Text] [Related]
32. [Penicillamine-induced dermolytic dermatosis in a patient with Wilson's disease (author's transl)]. Bardach H, Gebhart W. Dermatologica; 1981 Jul 31; 162(6):473-83. PubMed ID: 7274508 [Abstract] [Full Text] [Related]
33. [Possible accidents due to penicillamine during treatment of Wilson's disease]. Boudin G, Pépin B. Bull Acad Natl Med; 1972 May 31; 156(12):375-9. PubMed ID: 4572368 [No Abstract] [Full Text] [Related]
38. Treatment of Wilson's disease with triethylene tetramine dihydrochloride. A case report. Haslam RH, Sass-Kortsak A, Stout W, Berg M. Dev Pharmacol Ther; 1980 Oct 31; 1(5):318-24. PubMed ID: 7438976 [Abstract] [Full Text] [Related]
39. [A syndrome similar to systemic lupus erythematosus caused by penicillamine in patients with Wilson's disease]. Kalina P, Procházková L, Hauftová D. Bratisl Lek Listy; 1985 Sep 31; 84(3):336-40. PubMed ID: 4041939 [No Abstract] [Full Text] [Related]